RFU announces new deal with GSK
January 17, 2012
Stuart Lancaster leads England into the 2012 Six Nations which starts on February 4 © Getty Images
The Rugby Football Union (RFU) has announced that they have signed a four-year sponsorship deal with GlaxoSmithKline (GSK).
GSK are responsible for products such as Lucozade and Maximuscle with both now being used by the England rugby squads from senior level down to youth. The news follows a turbulent period in the RFU's history which saw CEO John Steele depart and former chairman Martyn Thomas departing soon after. But the announcement marks the first commercial deal since Sophie Goldschmidt left the NBA to take over as the RFU's chief commercial officer.
And Goldschmidt is delighted with the deal that will run until 2016 - taking in the 2015 World Cup in the process.
"We are excited about our new strategic partnership with GSK's Consumer Healthcare business," Goldschmidt said. "Lucozade Sport and Maximuscle are leaders in their field and are highly respected within the industry. This partnership will benefit all levels of the RFU's elite game, providing products and tailored nutritional expertise to England's Senior, Saxons, Sevens and Women's squads - this reinforces our commitment to excellence across all levels."
© ESPN Sports Media Ltd.
The rolling maul is becoming an increasingly potent attacking weapon. Conor O'Shea looks at the difficulties of stopping it
The news of James Horwill, Adam Ashley-Cooper and Dan Carter's respective transfers will open the floodgates, writes Tom Hamilton
Kiwi coaches can be found far and wide across the globe, and Murray Mexted believes the All Blacks benefit every bit as much as their rivals
Clermont, Toulon, player burnout, Sam Burgess and a farewell to Adams Park - Monday Maul looks back at the weekend's action